LLY
ELI LILLY & CoB7515-min delayed · EOD close1150.99 −1.64% downas of 2026-09-23mkt cap $1.1T
Pharmaceutical Preparations · SIC 2834 · CIK 0000059478
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $86.5B | 2026-09-30 | 10-Q · 0000059478-26-000108 |
| Revenue (prior year) | $45.0B | 2024-12-31 | 10-K · 0000059478-25-000067 |
| Net income | $27.6B | 2026-09-30 | 10-Q · 0000059478-26-000108 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $148B | 2026-09-30 | 10-Q · 0000059478-26-000108 |
| Current assets | $65.3B | 2026-09-30 | 10-Q · 0000059478-26-000108 |
| Current liabilities | $47.0B | 2026-09-30 | 10-Q · 0000059478-26-000108 |
| Shareholders' equity | $40.3B | 2026-09-30 | 10-Q · 0000059478-26-000108 |